Wolverine Trading, LLC Rigel Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $12,432 - $17,427	11,100 Added 48.47%	34,000 $50,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $5,760 - $12,480	8,000 Added 53.69%	22,900 $33,000
Q3 2023 Nov 15, 2023	SELL	$1.07 - $1.39 $963 - $1,251	-900 Reduced 5.7%	14,900 $16,000
Q2 2023 Aug 23, 2023	SELL	$1.12 - $1.82 $5,152 - $8,372	-4,600 Reduced 22.55%	15,800 $20,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $25,500 - $40,800	20,400 New	20,400 $27,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $23,100 - $256,199	21,000 New	21,000 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $9,179 - $43,703	-13,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $11,100 - $17,250	-5,000 Reduced 26.74%	13,700 $41,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $50,504 - $76,398	-21,400 Reduced 53.37%	18,700 $50,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $6,650 - $8,550	-1,900 Reduced 4.52%	40,100 $146,000
Q2 2021 Aug 06, 2021	BUY	$3.09 - $4.54 $309 - $454	100 Added 0.24%	42,000 $187,000
Q1 2021 May 14, 2021	BUY	$3.35 - $4.93 $12,060 - $17,748	3,600 Added 9.4%	41,900 $142,000
Q4 2020 Feb 12, 2021	BUY	$2.35 - $3.74 $51,465 - $81,906	21,900 Added 133.54%	38,300 $139,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $11,748 - $27,258	-6,600 Reduced 28.7%	16,400 $38,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $19,760 - $27,284	-7,600 Reduced 24.84%	23,000 $74,000
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $66,552 - $85,352	18,800 Added 159.32%	30,600 $108,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $75,582 - $100,620	-23,400 Reduced 66.48%	11,800 $46,000
Q3 2017 Nov 15, 2017	BUY	$2.18 - $2.57 $76,736 - $90,464	35,200	35,200 $89,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account